Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1

Giulia Schiroli,Samuele Ferrari,Anthony Conway,Aurelien Jacob,Valentina Capo,Luisa Albano,Tiziana Plati,Maria C Castiello,Francesca Sanvito,Andrew R Gennery,Chiara Bovolenta,Rahul Palchaudhuri,David T Scadden,Michael C Holmes,Anna Villa,Giovanni Sitia,Angelo Lombardo,Pietro Genovese,Luigi Naldini,Maria C. Castiello,Andrew R. Gennery,David T. Scadden,Michael C. Holmes

DOI: https://doi.org/10.1126/scitranslmed.aan0820

IF: 17.1

2017-10-11

Science Translational Medicine

Abstract:Preclinical studies establish the conditions for safe and effective correction of SCID-X1 by targeted gene editing of hematopoietic stem cells.

cell biology,medicine, research & experimental